CS
OMIC

Credit Suisse’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Credit Suisse’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– -$4 – 3822
2022
Q4 		– Sell
-11
Closed -$737 – 3850
2022
Q3 		$1K Buy
11
+9
+450% +$940 ﹤0.01% 3966
2022
Q2 		$0 Buy
+2
New +$235 ﹤0.01% 4431

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse's OMIC Position: Q1 2023 in Review

Credit Suisse held its Singular Genomics Systems, Inc. Common Stock (OMIC) position steady in Q1 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3822.

Credit Suisse first reported a position in OMIC in Q2 2022 and has held it in 2 quarters since. The position peaked at $1K in Q3 2022. 66 funds tracked by Wall St. Rank hold OMIC as of Q1 2023.

  • Credit Suisse held 0 shares of Singular Genomics Systems, Inc. Common Stock worth $0 as of Q1 2023.
  • Credit Suisse left its Singular Genomics Systems, Inc. Common Stock share count unchanged in Q1 2023.
  • Singular Genomics Systems, Inc. Common Stock made up ﹤0.01% of Credit Suisse's portfolio in Q1 2023, its #3822 holding.
  • Credit Suisse first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2022 and has held it in 2 quarters since.
  • Credit Suisse's Singular Genomics Systems, Inc. Common Stock position peaked at $1K in Q3 2022.
  • 66 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.